Canada markets open in 2 hours 23 minutes

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0500+0.0500 (+5.00%)
At close: 04:00PM EDT
1.0200 -0.03 (-2.86%)
Pre-Market: 06:29AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 124.34M
Enterprise Value -15.69M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.92
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.72

Trading Information

Stock Price History

Beta (5Y Monthly) 1.66
52-Week Change 3-68.09%
S&P500 52-Week Change 3-6.69%
52 Week High 34.3100
52 Week Low 30.8400
50-Day Moving Average 31.0356
200-Day Moving Average 31.4447

Share Statistics

Avg Vol (3 month) 31.38M
Avg Vol (10 day) 3714.21k
Shares Outstanding 5126.62M
Implied Shares Outstanding 6N/A
Float 8118.83M
% Held by Insiders 10.04%
% Held by Institutions 134.83%
Shares Short (Jul 14, 2022) 412.61M
Short Ratio (Jul 14, 2022) 46.95
Short % of Float (Jul 14, 2022) 49.96%
Short % of Shares Outstanding (Jul 14, 2022) 49.96%
Shares Short (prior month Jun 14, 2022) 416.04M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 19, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Apr 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-9.75%
Return on Equity (ttm)-15.90%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.72M
Net Income Avi to Common (ttm)-21.85M
Diluted EPS (ttm)-0.1740
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)131.49M
Total Cash Per Share (mrq)1.04
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)58.94
Book Value Per Share (mrq)1.06

Cash Flow Statement

Operating Cash Flow (ttm)-16.94M
Levered Free Cash Flow (ttm)-8.11M